Cargando…
Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758065/ https://www.ncbi.nlm.nih.gov/pubmed/36539043 http://dx.doi.org/10.1016/j.jinf.2022.12.016 |
| _version_ | 1784851961058689024 |
|---|---|
| author | Li, Xue Peng, Kuan Cheng, Franco W.T. Lam, David C.L. Cheung, Ching Lung Chui, Celine S.L. Lai, Francisco T.T. Wan, Eric Y.F. Wong, Carlos K.H. Ma, Tiantian Yum, Samson H.H. Chan, Esther W.Y. Huang, Jian Dong Lau, Chak Sing Ip, Mary S.M. Wong, Ian C.K. |
| author_facet | Li, Xue Peng, Kuan Cheng, Franco W.T. Lam, David C.L. Cheung, Ching Lung Chui, Celine S.L. Lai, Francisco T.T. Wan, Eric Y.F. Wong, Carlos K.H. Ma, Tiantian Yum, Samson H.H. Chan, Esther W.Y. Huang, Jian Dong Lau, Chak Sing Ip, Mary S.M. Wong, Ian C.K. |
| author_sort | Li, Xue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9758065 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97580652022-12-19 Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac) Li, Xue Peng, Kuan Cheng, Franco W.T. Lam, David C.L. Cheung, Ching Lung Chui, Celine S.L. Lai, Francisco T.T. Wan, Eric Y.F. Wong, Carlos K.H. Ma, Tiantian Yum, Samson H.H. Chan, Esther W.Y. Huang, Jian Dong Lau, Chak Sing Ip, Mary S.M. Wong, Ian C.K. J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-03 2022-12-17 /pmc/articles/PMC9758065/ /pubmed/36539043 http://dx.doi.org/10.1016/j.jinf.2022.12.016 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Li, Xue Peng, Kuan Cheng, Franco W.T. Lam, David C.L. Cheung, Ching Lung Chui, Celine S.L. Lai, Francisco T.T. Wan, Eric Y.F. Wong, Carlos K.H. Ma, Tiantian Yum, Samson H.H. Chan, Esther W.Y. Huang, Jian Dong Lau, Chak Sing Ip, Mary S.M. Wong, Ian C.K. Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac) |
| title | Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac) |
| title_full | Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac) |
| title_fullStr | Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac) |
| title_full_unstemmed | Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac) |
| title_short | Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac) |
| title_sort | tuberculosis following two-dose sars-cov-2 vaccination with messenger rna vaccine (bnt162b2) and inactivated virus vaccine (coronavac) |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758065/ https://www.ncbi.nlm.nih.gov/pubmed/36539043 http://dx.doi.org/10.1016/j.jinf.2022.12.016 |
| work_keys_str_mv | AT lixue tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT pengkuan tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT chengfrancowt tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT lamdavidcl tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT cheungchinglung tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT chuicelinesl tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT laifranciscott tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT wanericyf tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT wongcarloskh tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT matiantian tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT yumsamsonhh tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT chanestherwy tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT huangjiandong tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT lauchaksing tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT ipmarysm tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac AT wongianck tuberculosisfollowingtwodosesarscov2vaccinationwithmessengerrnavaccinebnt162b2andinactivatedvirusvaccinecoronavac |